<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="7336" end="7339" sStart="7333" offset="3" sid="r7.1.use.v.0718" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="We use 9/10of the data to train the BPNN or the GPNN, and we use the remaining 1/10of data to test the model and estimate the prediction error, whichis how well the NN model is able to predict disease status in that1/10 of the data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="17149" end="17153" sStart="null" offset="35" sid="r7.1.use.v.0636" wn="1" wnkey="use%2:34:01::" annotator="cgozo" text="The five disease models we used varied in heritability from0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="13609" end="13614" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" annotator="comcgeetubb" text="Since we only &lt;b&gt;tried&lt;/b&gt; 27 different architectures,there may have been more appropriate architectures for these datasets." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="11187" end="11191" sStart="null" offset="100" sid="r11.true.j.0397" wn="1" wnkey="true%3:00:00::" annotator="vebatchelder" text="Therefore,the error estimates obtained by the BPNN or GPNN are very closeto the true error rate." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="16053" end="16059" sStart="null" offset="124" sid="r11.strong.j.0626" wn="1" wnkey="strong%3:00:00::" annotator="anfahmy" text="This may bepreventing it from over-fitting the way that the BPNN has done.Secondly, it is possible that the strong signal of the correct solutionin the simulated data caused the GP to quickly pick up that signal,and propagate trees with components of that model in the population.Because we have mutation set to 0%, there is never a large changeto the trees to lead them to explore in the other areas of the searchspace." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2105-4-28.anc" start="8973" end="8978" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" annotator="carichter" text="Table 1&lt;b&gt;shows&lt;/b&gt; the resultsfrom the traditional BPNN architecture optimization technique onone data set from each epistasis model generated with the two functionalSNPs only." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="25108" end="25113" sStart="null" offset="61" sid="r9.sense.n.0692" wn="2" wnkey="sense%1:10:00::" annotator="brubin" text="As mentioned previously, heritability,in the broad sense, is the proportion of total phenotypic varianceattributable to genetic factors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="16944" end="16949" sStart="null" offset="35" sid="r9.sense.n.0440" wn="2" wnkey="sense%1:10:00::" annotator="brubin" text="Heritability, in the broad sense, is theproportion of total phenotypic variance attributable to geneticfactors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="33766" end="33770" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" annotator="cgozo" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="4668" end="4672" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="veweser" text="These include initial population size, number ofgenerations, reproduction &lt;b&gt;rate&lt;/b&gt;, crossover &lt;b&gt;rate&lt;/b&gt;, and mutation &lt;b&gt;rate&lt;/b&gt; [ 14 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="4668" end="4672" sStart="null" offset="0" sid="null" wn="4 1" wnkey="null" annotator="jeneale" text="These include initial population size, number ofgenerations, reproduction &lt;b&gt;rate&lt;/b&gt;, crossover &lt;b&gt;rate&lt;/b&gt;, and mutation &lt;b&gt;rate&lt;/b&gt; [ 14 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="4668" end="4672" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" annotator="cgozo" text="These include initial population size, number ofgenerations, reproduction &lt;b&gt;rate&lt;/b&gt;, crossover &lt;b&gt;rate&lt;/b&gt;, and mutation &lt;b&gt;rate&lt;/b&gt; [ 14 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="4668" end="4672" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="brubin" text="These include initial population size, number ofgenerations, reproduction &lt;b&gt;rate&lt;/b&gt;, crossover &lt;b&gt;rate&lt;/b&gt;, and mutation &lt;b&gt;rate&lt;/b&gt; [ 14 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="31779" end="31784" sStart="null" offset="0" sid="null" wn="7" wnkey="power%1:07:02::" annotator="veweser" text="Weestimated the &lt;b&gt;power&lt;/b&gt; by calculating the percentage of datasets wherethe correct functional SNPs were identified." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="22161" end="22166" sStart="null" offset="0" sid="null" wn="6" wnkey="power%1:10:00::" annotator="veweser" text="The goal of the data simulation was to generate data sets thatexhibit gene-gene interactions for the purpose of evaluating theclassification error, prediction error, and &lt;b&gt;power&lt;/b&gt; of GPNN and atraditional BPNN." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="22161" end="22166" sStart="null" offset="0" sid="null" wn="1" wnkey="powerfulness%1:07:00::" annotator="tofox" text="The goal of the data simulation was to generate data sets thatexhibit gene-gene interactions for the purpose of evaluating theclassification error, prediction error, and &lt;b&gt;power&lt;/b&gt; of GPNN and atraditional BPNN." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="31779" end="31784" sStart="null" offset="0" sid="null" wn="2147483646" wnkey="null" annotator="jeneale" text="Weestimated the &lt;b&gt;power&lt;/b&gt; by calculating the percentage of datasets wherethe correct functional SNPs were identified." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="32959" end="32964" sStart="null" offset="0" sid="null" wn="2147483646" wnkey="null" annotator="carichter" text="We estimatedthe &lt;b&gt;power&lt;/b&gt; of GPNN as the number of times the functional SNPs wereidentified in the model divided by the total number of runs." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="31779" end="31784" sStart="null" offset="0" sid="null" wn="2147483646" wnkey="null" annotator="carichter" text="Weestimated the &lt;b&gt;power&lt;/b&gt; by calculating the percentage of datasets wherethe correct functional SNPs were identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="8576" end="8581" sStart="null" offset="131" sid="r9.paper.n.0975" wn="5" wnkey="paper%1:10:02::" annotator="cgozo" text="Further detail regarding the implementationof cross-validation can be found in the Data Analysis section ofthe paper." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="32980" end="32986" sStart="null" offset="47" sid="r8.number.n.0951" wn="1" wnkey="number%1:07:00::" annotator="brubin" text="We estimatedthe power of GPNN as the number of times the functional SNPs wereidentified in the model divided by the total number of runs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="26357" end="26363" sStart="null" offset="123" sid="r9.level.n.0487" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="We used a dummy variableencoding for the genotypes where n-1 dummy variables areused for n levels [ 40 ] . We simulated 100data sets of each epistasis model with two functional SNPs." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="6553" end="6559" sStart="null" offset="0" sid="null" wn="2" wnkey="island%1:06:00::" annotator="veweser" text="This is often referredto as an &quot;&lt;b&gt;island&lt;/b&gt; model&quot; [ 27 ] . This exchangeincreases diversity among the solutions in the different populations.Following the set number of generations, the best-so-far solutionsfrom each of the n processors are compared and a singlebest solution is selected." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="6553" end="6559" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" annotator="jeneale" text="This is often referredto as an &quot;&lt;b&gt;island&lt;/b&gt; model&quot; [ 27 ] . This exchangeincreases diversity among the solutions in the different populations.Following the set number of generations, the best-so-far solutionsfrom each of the n processors are compared and a singlebest solution is selected." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="6553" end="6559" sStart="null" offset="0" sid="null" wn="2" wnkey="island%1:06:00::" annotator="carichter" text="This is often referredto as an &quot;&lt;b&gt;island&lt;/b&gt; model&quot; [ 27 ] . This exchangeincreases diversity among the solutions in the different populations.Following the set number of generations, the best-so-far solutionsfrom each of the n processors are compared and a singlebest solution is selected." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="23061" end="23070" sStart="null" offset="204" sid="r11.function.n.0844" wn="2" wnkey="function%1:07:00::" annotator="vebatchelder" text="We simulateddata with two functional single nucleotide polymorphisms (SNPs)to compare GPNN to a BPNN for modeling nonlinear epistasis models.In this study, we use penetrance functions as genetic models." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="20654" end="20662" sStart="null" offset="20" sid="r11.function.n.0518" wn="2" wnkey="function%1:07:00::" annotator="anfahmy" text="The use of a richer function set, includingBoolean operators and other mathematical operators, may allow moreflexibility in the NN models." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="28182" end="28186" sStart="null" offset="10" sid="r9.fold.v.0837" wn="2147483645" wnkey="null" annotator="veweser" text="We used 10fold cross-validation to evaluate the predictive ability of theBPNN models." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="7230" end="7234" sStart="null" offset="78" sid="r9.fold.v.0616" wn="2147483645" wnkey="null" annotator="brubin" text="To evaluate the generalizabilityof BPNN and GPNN models, we used 10 fold cross-validation [ 29 30 ] (CV).Here, the data are divided into 10 parts of equal size." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="8525" end="8530" sStart="null" offset="80" sid="r10.find.v.0665" wn="4" wnkey="find%2:32:00::" annotator="veweser" text="Further detail regarding the implementationof cross-validation can be found in the Data Analysis section ofthe paper." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="13406" end="13415" sStart="null" offset="107" sid="r8.1.different.j.0060" wn="1" wnkey="different%3:00:00::" annotator="veweser" text="For one example data set from eachof the epistasis models, the best architecture was quite different,as shown in Table 1and Figure 5for functional SNP only data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="13406" end="13415" sStart="null" offset="107" sid="r8.1.different.j.0060" wn="1" wnkey="different%3:00:00::" annotator="jeneale" text="For one example data set from eachof the epistasis models, the best architecture was quite different,as shown in Table 1and Figure 5for functional SNP only data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="8930" end="8939" sStart="null" offset="208" sid="r8.1.different.j.0852" wn="1" wnkey="different%3:00:00::" annotator="cgozo" text="The results of our trial-and-error optimization technique forselecting the traditional BPNN architecture indicate the importanceof selecting the optimal NN architecture for each different epistasismodel." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="13406" end="13415" sStart="null" offset="107" sid="r8.1.different.j.0060" wn="1" wnkey="different%3:00:00::" annotator="cgozo" text="For one example data set from eachof the epistasis models, the best architecture was quite different,as shown in Table 1and Figure 5for functional SNP only data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="13406" end="13415" sStart="null" offset="107" sid="r8.1.different.j.0060" wn="1" wnkey="different%3:00:00::" annotator="brubin" text="For one example data set from eachof the epistasis models, the best architecture was quite different,as shown in Table 1and Figure 5for functional SNP only data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="15058" end="15066" sStart="null" offset="239" sid="r10.control.n.0960" wn="4" wnkey="control%1:09:02::" annotator="brubin" text="These results provide evidence that GPNN is able to detectthe functional SNPs and model the interactions for the epistasismodels described here with minimal main effects in a sample size of200 cases and 200 controls." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="23891" end="23903" sStart="null" offset="33" sid="r11.combination.n.0613" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="The high-risk genotype combinations are AaBB , Aabb , AABb ,and aaBb with disease penetrance of 0.1 for all four." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="23288" end="23299" sStart="null" offset="90" sid="r11.combination.n.0638" wn="1" wnkey="combination%1:14:00::" annotator="anfahmy" text="Penetrance is defined as the probability of diseasegiven a particular combination of genotypes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="31478" end="31484" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="Through permutation testing,we determined an empirical cutoff for the cross-validation consistencythat would not be expected by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="31478" end="31484" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" annotator="comcgeetubb" text="Through permutation testing,we determined an empirical cutoff for the cross-validation consistencythat would not be expected by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-4-28.anc" start="31478" end="31484" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="Through permutation testing,we determined an empirical cutoff for the cross-validation consistencythat would not be expected by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="21435" end="21439" sStart="null" offset="27" sid="r11.able.j.0667" wn="1" wnkey="able%3:00:00::" annotator="vebatchelder" text="We have shown that GPNN is able to model gene-geneinteractions as well as a BPNN in data containing only the functionalSNPs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="27082" end="27086" sStart="null" offset="82" sid="r11.able.j.0256" wn="1" wnkey="able%3:00:00::" annotator="vebatchelder" text="In the first stage of analysis, we posed the following question:Is GPNN able to model gene-gene interactions as well or better thana traditional BPNN?" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="7550" end="7554" sStart="null" offset="217" sid="r11.able.j.0212" wn="1" wnkey="able%3:00:00::" annotator="anfahmy" text="We use 9/10of the data to train the BPNN or the GPNN, and we use the remaining 1/10of data to test the model and estimate the prediction error, whichis how well the NN model is able to predict disease status in that1/10 of the data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="12291" end="12295" sStart="null" offset="8" sid="r11.able.j.0999" wn="3" wnkey="able%5:00:00:capable:00" annotator="adelpriore" text="GPNN is able to modelgene-gene interactions and develop NN models that can generalizeto new observations." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="29984" end="29988" sStart="null" offset="35" sid="r11.able.j.0366" wn="3" wnkey="able%5:00:00:capable:00" annotator="adelpriore" text="potentialfalse-positives), is GPNN able to detect gene-gene interactionsas well or better than a traditional BPNN?" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-4-28.anc" start="11427" end="11431" sStart="null" offset="67" sid="r11.able.j.0234" wn="3" wnkey="able%5:00:00:capable:00" annotator="adelpriore" text="These results demonstrate that the BPNN and GPNNare both able to model the nonlinear gene-gene interactions specifiedby these models." />
  </sentences>
</list>